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ABSTRACT 
Nucleus pulposus (NP) tissue damage can induce detrimental mechanical strain on the 
biomechanical performance of intervertebral disc (IVD) causing subsequent disc 
degeneration. A novel, photocurable, injectable, synthetic polymer hydrogel 
(pHEMA-co-APMA grafted with PAA) has already demonstrated success in 
encapsulating and differentiating human mesenchymal stem cells (hMSCs) towards 
an NP phenotype during hypoxic conditions. After demonstration of promising results 
in our previous work, in this study, we have further investigated the inclusion of 
mechanical stimulation and its impact on hMSC differentiation towards an NP 
phenotype through the characterization of matrix markers such as SOX-9, Aggrecan 
and Collagen II.  Furthermore, investigations were undertaken in order to approximate 
delivery parameters for an injection delivery device, which could be used to transport 
hMSCs suspended in hydrogel into the IVD. hMSC laden hydrogel solutions were 
injected through various needle gauge sizes in order to deter its impact on post-
injection cell viability and IVD tissue penetration. Interpretation of this data informed 
the design of a potential minimally invasive injection device, which could 
successfully inject hMSCs encapsulated in a UV curable polymer into NP, prior to 
photocrosslinking in situ.  
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INTRODUCTION 
Biomechanical and pathohistological structure changes occur in the degenerated 
intervertebral disc (IVD). The difficulty in IVD tissue to repair and regenerate itself is 
attributed to its relatively acellular (5000 cells/mm3), acidic and avascular 
environment. Subsequently, when considering an acellular or tissue engineering 
therapy for the IVD, several factors must be considered including: extracellular 
matrix architecture, hydrated tissue matrix, hypoxic nature and the mechanical 
stresses and strains imposed upon the nucleus pulposus (NP) tissue. For this reason, 
hydrogels are an ideal and popular choice, as they are able to offer a hydrated 
environment, the ability to mimic native fibrillar structure and are biocompatible 1,2. 
Furthermore, photocurable hydrogels display additional benefits, including fine-
tuning mechanical properties and swelling behavior, short-reaction times, minimal 
heating and minimally invasive delivery. To date, only a single study exists which has 
displayed the successful use of a photocurable polyethyelene glycol diacrylate 
hydrogel to encapsulate and differentiate MSCs towards NP-like cells, proven by the 
positive expression of typical NP matrix proteins (Aggrecan and Collagen II) 3.   
Various parameters have been demonstrated to influence the differentiation of hMSCs 
towards an NP cell-like phenotype including: a 3D environment supported by 
hydrogels 4, hypoxia and chemical stimulation and disc microenvironment 5. A study 
by Stoyanov et al demonstrated the successful differentiation of hMSCs towards NP 
cells under the combined influence of 3D encapsulation using alginate beads and 
chemical media 6. Recently, our group demonstrated the successful use of a novel, 
synthetic, UV photocurable hydrogel p(HEMA-co-APMA)g PAA for the 
encapsulation of hMSCs and their differentiation towards an NP- cell like phenotype 
7. In this case, differentiation was achieved through the multiple combinatorial effects 
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of 3D encapsulation, chondrogenic media and hypoxia. In this study, we have further 
investigated the added influence of mechanical stimulation to hMSC differentiation 
and also demonstrated the feasibility of cell delivery using injection devices. 
 
MATERIALS AND METHODS 
Preparation of Photocurable Hydrogel Solution 
pHEMA-APMA-PAA polymer was prepared as described previously 7. Briefly, 
hydrogels were prepared at 13.5 % (w/v) concentration by dissolving the required 
amount of polymer in phosphate buffer saline (PBS). 50 % (w/v) Irgacure 2959 
(prepared using DMSO) solution was added to the polymer solution at 1 % volume of 
the total polymer solution. Polymer solution was briefly vortexed and sterile filtered 
before use. 
 
hMSC, expansion, Encapsulation in Hydrogels and Differentiation towards NP like 
Cells 
hMSCs from fresh human bone marrow aspirate (Lonza, UK) was recovered, isolated 
and expanded as described previously by Pittenger et. al. 8.  hMSCs were expanded 
using hMSC expansion media which consisted of: DMEM, 10% Fetal bovine serum 
(FBS; Lonza, UK), 1% L-glutamine (L-glut; Lonza, UK), 1% non-essential amino 
acids (NEAA; Lonza, UK) and 1% penicillin and streptomycin and incubated in an 
hypoxic chamber at 2% O2 SCI-Tive workstation (RUSKINN Technology, The Baker 
Company). Seeding solutions consisted of 200 000 cells/50 μl of hMSC media per 
hydrogel. Cell seeding solution and cross-linking was performed as mentioned in our 
previous work 7. Chondrogenic media (consisting of: DMEM, 1% FBS, 1% NEAA, 
1% L-glut, 0.1μM dexamethasone, 50μM ascorbic acid, 40μg ml-1 L-proline, 1% 
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sodium pyruvate and 10ng ml-1 TGF-β3) was conditioned in hypoxia at 2% O2 using 
the SCI-Tive workstation for 24 hours, prior to use. Mechanical stimulation to 
biological samples was applied using the BOSE bioreactor. Stimulation parameters of 
cyclic compression (5%) at 1Hz for 15 mins a day, up to day 7 or 14 were applied. 
Hydrogels encapsulated with hMSCs cultured under hMSC or chondrogenic media, 
under hypoxia were loaded into the biodynamic chamber using sterile forceps. 
Mechanical stimulation was performed for 15 mins, after which point, samples were 
placed back into culture within the SCI-Tive workstation until the following day.  
 
PCR Analysis of Chondrogenic Markers (Static vs Mechanical stimulation) 
One-step qRT-PCR was performed using the Superscript III Platinum SYBR green 
enzyme (Part #: 11736051; Invitrogen, Paisley, UK), according to manufacturers’ 
instructions. Primers (F indicates Forward primer, R indicates Reverse primer, 
annealing temperature used is indicated for each primer pair) were purchased from 
Qiagen, UK (Aggrecan, ACAN, Part #: QT00001365; Collagen II, SLCO2A1, Part #: 
QT00095375; SOX-9, Part #: QT00001498 and GAPDH, Part #: QT01192646). All 
qRT-PCR reactions comprised a single cycle of 50 ᵒC for 3 mins, a single cycle of 95 
ᵒC for 5 mins, followed by 40 cycles of 95 ᵒC for 15 secs, annealing temp for 45 ᵒC 
for 30 secs and 72 ᵒC for 1 min; finally followed by a single cycle of 40 ᵒC for 1 min 
using the thermo cycler machine. Raw CT values of interested genes were normalized 
to raw CT values of the housekeeping gene GAPDH to attain Δ CT values per gene. 
These values were then converted to ΔΔ CT values, which were the final values used 
in the graph.  
 
Evaluation of Cell Viability after Injection through Different Needle Gauges 
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Trypsinised hMSCs were resuspended homogenously into the polymer hydrogel 
solution (pre-photocuring) at a cell density of 100 000 cells / 50 µl polymer solution. 
hMSC/polymer solutions were injected using different hsurgical gauge size needles 
(19G, 22G, 27G and 30G; Terumo, UK) into a 6-well plate and incubated at 2% O2 
for 1hr and 24hrs after which cell viability was evaluated using trypan blue and  
live/dead staining solutions (FLUKA Analytical, Sigma-Aldrich), as used previously 
in our study 7. 
 
IVD Penetration Force Study 
Frozen Oxtail IVDs were thawed down to room temp prior to use. Various sized 
needles (22G, 25G, 27G and 30G) were fixed to a compressive testing machine 
(Model 5848; Instron Ltd, UK). This was achieved using a stainless steel adaptor 
(Figure 4A) that could receive a 2ml syringe barrel with reduced length and a tip for 
needle attachment (Terumo Ltd, UK). The bespoke adaptor attached to the mobile 
upper jaw of the testing machine.  
The machine was set in compression mode with a 5N load cell installed and the 
mobile upper-jaw of the tester was programmed to travel at a rate of 1mm.s-1. The Ox 
tail was affixed to a polystyrene sheet using spare needles to prevent sample from 
moving during penetration (Figure 4B). For each experiment, the needle was pushed 
into the IVD by approximately 5mm. This penetration depth ensured the needle 
pushing past the annulus fibrosis and entered into the nucleus pulposus. 
 
 
 
 
Copyright © 2016 Cognizant Communication Corporation 
 
7 
CT-1623 Cell Transplantation early e-pub; provisional acceptance 07/20/2016          
RESULTS AND DISCUSSION 
Effects of 3D culture and cyclic compression 
In this study, further insights were examined in terms of specifying the power and 
impact of each of the stimulating parameters (hydrogel, hypoxia, chemical 
environment and mechanical stimulation) individually on the differentiation process 
of hMSCs towards an NP-cell like phenotype. PCR analysis revealed that 3D culture 
of hMSCs within the hydrogel under hypoxic conditions triggered the differentiation 
of hMSCs towards an NP-cell like phenotype (Figure 1).  This was evidently shown 
through elevated gene expression of SOX-9 (Figure 1A), aggrecan (Figure 1B) and 
collagen II (Figure 1C) at day 14 when compared to 2D culture, in hMSC media. 
When combining cell-gel constructs under hypoxia and in chondrogenic media, gene 
expression of SOX-9 (Figure 1A), Aggrecan (Figure 1B) and Collagen II (Figure 
1C) were further elevated at day 14. However, the significant decrease in gene 
expression from day 7 to day 14, when cell hydrogel constructs were in hypoxia and 
chondrogenic media, may have been attributed to the complete transcriptional switch 
from a stem cell to a terminally differentiated NP cell-like phenotype and that 
translational expression of matrix proteins could take place after day 7 during in vitro 
culture.  
We next integrated mechanical stimulation to the study and investigated the effects of 
5% cyclic compression, 1Hz, 15 mins a day and up to day 14, on hMSCs 
encapsulated within hydrogels, under hypoxia, in hMSC or chondrogenic media. 
Immunocytochemistry was used to reveal the translational expression of key NP 
matrix proteins aggrecan and collagen II. Minimal differences in expression of Agg 
and Coll II were witnessed when culturing hMSCs (2D, on tissue culture plastic 
(TCP); or 3D, cells encapsulated within hydrogels) in hMSC media under hypoxia 
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(Figure 2A and 2C).  However, it was apparent that after the addition of 
chondrogenic media, further elevated levels of aggrecan and collagen II were 
witnessed when cultured under hypoxic conditions for 14 days (Figure 2B and 2D). 
Interestingly, the greatest level of translational expression of both aggrecan and 
collagen II was witnessed in hydrogels cultured in hypoxia and chondrogenic media 
and exposed to mechanical stimulation up to day 14 (Figure 2). This in vitro 3D 
culture with mechanical stimulation demonstrated the ability to support hMSC 
viability and differentiation towards an NP cell-like phenotype. However, further 
improvements to the model can be made in order to mimic the mechanical stimulation 
parameters close to the biomechanics of IVD by applying more long-term mechanical 
stimulation regime.  
 
Post-injection viability of cells  
Coupled together, with the ability of the hydrogels to provide protection to the 
encapsulated cells and mechanical support to the surrounding tissue in vivo, the ability 
to deliver cells in a minimally invasive procedure to the target site as well as the 
ability of the hydrogel to photocure in situ after delivery, encouraged the 
consideration in the delivery parameters for a device which would be used for local 
delivery of cell-laden hydrogel solution in vivo. To minimize the damage to the IVD 
from the needle penetration, needles with smaller diameter are ideal. However, 
narrower needle gauges could cause damage to the cells due to shear stresses imposed 
within the needle bore. Hence, the logical step in determining the most suitable needle 
gauge (Figure 3A) to deliver hMSC-laden hydrogels was to establish the effect of the 
inner diameter of the needle used on cell viability after delivery.  
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Heng et al 2012 9 have reported that passing hMSCs through a narrower catheter (26G 
nitinol needle lumen) at flow rates, which are normally encountered, resulted in no 
changes in hMSC multipotency or viability. This was an intramyocardial injection of 
hMSCs directly into heart muscle. In another study by Garvican et al, 2014 10; no 
changes in stem cell differentiation was observed when injected through 19G, 21G or 
23G needles. However, there was a compromise in viability injecting through 21G 
and 23G needles. The general consensus therefore appears to be the preference by 
clinicians for smaller bore needles for hMSC delivery 11. 
 
As the proposed route of delivery is to: 1) inject cell hydrogel solution in situ 
followed by, 2) cross-linking using a UV source, it was imperative to investigate 
various needle gauges (22G, 25G, 27G and 30G) and the impact on cell viability. 
Observations revealed that after injection, hMSCs retained good cell viability on TCP 
with the ability to fully recover their typical fibroblastic morphology in 24 hrs 
(Figure 3B). Insignificant differences in viability were observed between 22G, 25G 
and 27G, although significant differences in cell viability were witnessed with 30G 
compared to all other sizes (Figure 3B and C). This data lies in agreement with 
literature suggesting the use of 22G to 27G needles. The minimal cell death maybe 
attributed to the masking/protection of cells through the viscosity of the polymer from 
the impact of shear forces applied by these needles 12,13. However, a limitation of this 
experiment includes the inability to control the flow rates precisely, which could 
contribute to the large standard deviation on average number of dead cells observed in 
Figure 3C.  Future studies could include delivery using various flow rates controlled 
by a electrical motor, but we feel the manual injection would reflect the manner of 
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stem cells delivery more close to the medical procedures deployed in a clinical setting 
14,15. 
After delivery, photo-crosslinking of cell loaded hydrogel solution would take place 
in situ where our previous study and others have confirmed insignificant compromise 
on viability using the photoinitiator (Irgacure 2959) and the UV parameters 7. In 
addition, no secondary surgical intervention would be required after therapy, as the 
hydrogel is designed/tailored to breakdown with degradation products less than 
20kDa (limit for renal filtration), allowing smooth excretion of the polymer-by-
products through the metabolic pathway efficiently, preventing subsequent localised 
accumulation of hydrogel by-products 16. 
 
Quantification of tissue penetration force 
Needle penetration forces into IVD were investigated using an ex vivo tissue model. 
Explant IVD tissue from Ox tail (with similar dimensions and mechanical properties 
to human IVD) was penetrated using different needle gauges (Figure 4A-C). Greater 
variation in penetration force was observed using larger needle gauge and is probably 
attributed to the larger outer diameter of the needle resulting in greater and controlled 
tearing of the tissue as it penetrates through the Annulus Fibrosus (AF) (Figure 4D). 
The 22G needle was shown to require the greatest mean force to penetrate 2.17N 
(1.39%SD), the 30G needle was shown to have the lowest force to penetrate with the 
penetration point being the most consistent with a mean of 0.51 N (0.04% SD) 
(Figure 4D). Smaller penetration forces were encountered using smaller needles, but 
it is also important to ensure that cell viability is not compromised through direct 
shear forces, although this does not appear to be the case here. Hence, the selection of 
delivery device parameters would be a negotiation between the internal diameter to 
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ensure cell viability and the request of a small needle gauge to ensure negligible effect 
on IVD integrity 17,18. It is anticipated that a suitable minimally invasive delivery 
device must be able to exert approximately a force of 2.5N, which is required to 
successfully penetrate through the AF of an IVD. The needle gauge of the device 
could be in the range of 19-30G, although using a smaller bore needle can minimise 
penetration forces, but also it will increase the pressure required on the back of a 
syringe, most likely when a viscous hydrogel solution is delivered.  
 
Delivery device deign  
Having taken all parameters and outcomes into consideration, the formulated CAD 
model of the chosen delivery design is displayed in Figure 4D. Major design 
components include: a consumable cell reservoir of hMSCs and hydrogel solution, 
battery-powered stepper motor with controlled injection and corresponding control 
and feedback components. This allows accurate and precise volumetric delivery via 
an electromechanical device facilitating intelligent control of the delivery force. The 
possibility of a battery device improves its ergonomic performance, as no wires would 
hinder the final positional control by the surgeon. Briefly, injection of hMSC loaded 
hydrogel solution is controlled through a rocker trigger activated with the users 
forefinger. However, further investigations would be required to perform proof of 
concept studies using the device with an in vivo pre-clinical model (bovine or ovine). 
Preliminary assessment of the injectable parameters has provided insights into the 
design of an injection device capable of delivering a UV-curable hydrogel loaded 
with hMSCs that could be used to inject through the AF and into IVD. It is anticipated 
that the delivery method would be minimally invasive. This is attributed to the fact 
that the device would have a narrow enough needle to penetrate through the AF and 
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into the NP. The cannula would then be changed to allow injection/delivery of the 
hMSC loaded polymer solution with the photo-initiator to the delivery site. Following 
delivery, a probe would then followed through the catheter to the target site allowing 
the exposure of UV light with optimized parameters to permit photocuring in situ. 
Once cured the properties of the hydrogel would help to restore mechanical function 
of IVD for the time being 2,19 until developmental state of hMSCs and cell/scaffold 
interactions are proper for effective ECM production, hence, contributing to the repair 
of NP tissue 5,20,21. 
Conclusion 
This study has demonstrated the successful use of a UV photocurable, synthetic, 
hydrogel in encapsulating hMSCs and differentiating them towards an NP cell-like 
phenotype when cultured in a combined environment of hypoxia, chemical 
stimulation and mechanical stimulation. In addition, we have considered the delivery 
route of the cell loaded hydrogel solution in situ, have demonstrated adequate cell 
viability and morphology after injection using 22G and 27G needles and quantified 
the force required for successful penetration through the AF.  
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FIGURE LEGENDS 
 
Figure 1. Gene expression. Real time PCR demonstrating the expression of typical 
IVD markers; (A) SOX-9, (B) Aggrecan, (C) Collagen II in primary chondrocytes 
(OK cells) and hMSCs cultured in 2D and 3D (hydrogels) environments, in hMSC or 
chondrogenic media, under static or stimulated conditions in hypoxia up to 14 days. 
Annotations: Human Chondrocytes (OK), MSCs cultured in MSC expansion media 
(MSC MM), MSCs cultured in chondrogenic media (MSC CM), on tissue culture 
plastic (2D) and within hydrogels (3D).  
 
Figure 2. IVD matrix protein expression. Immunocytochemistry demonstrating the 
expression of typical IVD matrix proteins; Collagen II expression in hMSCs cultured 
within hydrogels under static and stimulated conditions at day 7 and day 14 of culture 
in: (A) hMSC differentiation media and (B) in chondrogenic media. Aggrecan 
expression in hMSCs cultured within hydrogels under static and stimulated conditions 
at day 7 and day 14 of culture in : (C) hMSC differentiation medium and (D) 
chondrogenic medium.     
 
Figure 3. Injection delivery route evaluation using different needle gauge sizes. (A) 
Defines the dimensions of the different sized gauge needles used to inject hMSCs into 
a well plate. (B) hMSC viability (live/dead staining) 24 hours after injection through 
various sized needle gauges. (C) Quantification of the percentage of hMSC dead cells 
(trypan blue) 1 hour after injection through various sized needle gauges.   
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Figure 4. IVD penetration force in an ex vivo bovine model. (A) Bespoke adaptor 
assembled with the syringe component to connect the various sized needle gauges 
used in the study, (B) sectioned oxtail vertebrae, (C) ex vivo tissue being injected 
using a needle mounted on the materials tester, (D) box plot revealing IVD 
penetration forces required by the various needle gauge sizes used, (E) CAD design 
visualization of a potential injection device to deliver UV curable hydrogel (left) and 
a UV light source (right) for the treatment of IVD in vivo.  
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